Why Novavax Stock Is Soaring Today

Shares of Novavax (NASDAQ: NVAX) were up 8.1% as of 10:22 a.m. EST on Friday after rising as much as 15.8% earlier in the session. The big gain came after the company announced impressive results from the final analysis of a late-stage study evaluating COVID-19 vaccine candidate NVX-CoV2373.

Investors clearly think that Novavax's final analysis increases the likelihood that NVX-CoV2373 will win Emergency Use Authorization (EUA) in the U.K. and the U.S. They're probably right.

Image source: Getty Images.

Continue reading

Source Fool.com